AlphaStocks
7.4
Consider Buy

West Pharmaceutical Services Inc (WST)

As of Sep 20, 2026, West Pharmaceutical Services Inc (WST) scores 7.4/10 on AlphaStocks' five-model composite, #10 of 168 Health Care stocks. At $362, WST trades 81% above its model fair value of $200.

Health Care / Health Care Supplies

S&P 500

$361.82

Above average across most dimensions. A solid candidate.

Consider Buy

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#10out of 168 in Health Care

Is WEST PHARMACEUTICAL SERVICES INC a Good Investment in 2026?

WEST PHARMACEUTICAL SERVICES INC (WST) scores 7.4 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates WEST PHARMACEUTICAL SERVICES INC as Strong (7/9). However, the Greenblatt Magic Formula model rates it Caution — Earnings yield 2.9% · ROC 24%. WEST PHARMACEUTICAL SERVICES INC currently trades 81% above its estimated fair value of $200. WEST PHARMACEUTICAL SERVICES INC ranks #10 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E53.3ROE11.4Market Cap26B

Estimated Fair Value

$199.8681% above

Trading above estimated fair value. P/e of 53x implies high growth expectations. eps growth of 2% may not justify the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Strong

Business quality & competitive moat

Graham

Neutral

Significantly above fair value

Lynch

Neutral

High PEG — growth premium · Stalwart

Greenblatt

Caution

Earnings yield 2.9% · ROC 24%

Frequently Asked Questions

Is WEST PHARMACEUTICAL SERVICES INC (WST) a good investment?
As of Sep 20, 2026, West Pharmaceutical Services Inc (WST) scores 7.4/10 on AlphaStocks' five-model composite, #10 of 168 Health Care stocks. At $362, WST trades 81% above its model fair value of $200. That score is above average across most investment dimensions.
What is WEST PHARMACEUTICAL SERVICES INC's Piotroski F-Score?
WEST PHARMACEUTICAL SERVICES INC's Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is WST overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $200, WST appears overvalued. The stock currently trades 81% above its estimated fair value. Trading above estimated fair value. P/e of 53x implies high growth expectations. eps growth of 2% may not justify the premium.
How does WST compare to other Health Care stocks?
WEST PHARMACEUTICAL SERVICES INC ranks #10 out of 168 stocks in the Health Care sector, placing it in the top 6% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about WST?
AlphaStocks evaluates WST using five proven investment models. Piotroski: Strong; Buffett: Strong; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 7.4/10.

Similar Stocks

LNTHMMSIHAE

Compare WST with

LNTH vs WSTMMSI vs WSTHAE vs WSTPARR vs WST

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer